42.5
Stamceltherapie voor weefselregeneratie
Stamceltherapie is een methode die in de regeneratieve geneeskunde wordt gebruikt om de functie van beschadigde weefsels en organen te herstellen en t…
Stem cells are unspecialized cells that can self-renew or differentiate into tissue-specific cells.
Due to the unique properties of these cells, stem cell therapy can be used to regenerate damaged or diseased tissues and organs.
Cancer patients with impaired bone marrow functions, such as those diagnosed with leukemia, lymphoma, and myeloma, are often candidates for stem cell therapy.
Bone marrow, a spongy tissue found in the center of large bones, is the main source of hematopoietic or blood-forming stem cells. Without healthy bone marrow, a patient cannot produce blood cells.
To start stem cell therapy, blood cancer patients are first exposed to high doses of radiation or chemotherapy to destroy cancerous cells — a conditioning therapy. This may also affect their original stem cells.
Then, hematopoietic stem cells harvested from the patient — an autologous transplant — or a healthy matching donor — an allogeneic transplant — are infused intravenously into the patient.
Over time, the transplanted stem cells proliferate in the bone marrow and restore the patient’s ability to produce healthy blood cells.
View the full transcript and gain access to JoVE Core videos
Q1: What are stem cells and why are they used in therapy?
Stem cells are unspecialized cells capable of self-renewal and differentiation into tissue-specific cells. Their unique properties make them ideal for regenerative medicine, allowing them to repair and restore function to damaged or diseased tissues and organs. This potential has made stem cell therapy a promising treatment for various conditions, including blood cancers and organ damage.
Q2: How do hematopoietic stem cells help treat blood cancer patients?
Blood cancer patients with impaired bone marrow function receive conditioning therapy—high-dose radiation or chemotherapy—to destroy cancerous cells. Hematopoietic stem cells from the patient or a healthy donor are then infused intravenously. These transplanted cells proliferate in the bone marrow, restoring the patient's ability to produce healthy blood cells and recover bone marrow function.
Q3: What is the difference between autologous and allogeneic stem cell transplants?
Autologous transplants use hematopoietic stem cells harvested from the patient's own bone marrow, while allogeneic transplants use cells from a healthy matching donor. Both approaches aim to restore blood cell production after conditioning therapy. The choice depends on the patient's health condition and availability of matched donors.
Q4: Why are adult stem cells preferred over embryonic stem cells in therapy?
Adult stem cells, such as hematopoietic and mesenchymal stem cells, are more commonly used because embryonic stem cells require embryo sacrifice, raising significant ethical concerns. Although adult stem cells have limited differentiation potential compared to embryonic stem cells, they can still differentiate into various tissue types and are readily available from bone marrow and umbilical cord blood.
Q5: How does the timing of stem cell administration affect tissue repair?
Timing is crucial for repair efficiency when stem cells are administered directly to target tissues. If introduced too early after injury, the inflammatory process impairs stem cell proliferation. However, when administered during the repair phase, stem cells are more readily incorporated into tissue and can proliferate effectively to repair damage.
Q6: What factors determine the success of stem cell therapy strategies?
Stem cell therapy success depends on optimization of multiple factors: the source of stem cells, the target tissue, and the recipient's health condition. Administration route also matters—intravenous delivery works for bone marrow establishment, while direct administration at the target site is more efficient for local tissue repair in organs like the heart, kidney, liver, and muscle.
Q7: What types of tissues can mesenchymal stem cells differentiate into?
Mesenchymal stem cells, found primarily in bone marrow and umbilical cord blood, can differentiate into multiple tissue types including heart, liver, muscle, bone, and some nerve tissues. This broad differentiation potential makes them valuable for regenerative therapy applications targeting various organ systems and tissue types.